Biologics May Lower Cardiovascular Risk in Patients With RA

The use of bDMARDs in patients with RA may have additional beneficial effects on arterial wall inflammation, independent of systemic inflammation.
Medscape Medical News

source https://www.medscape.com/viewarticle/biologic-drugs-may-mitigate-cardiovascular-event-risks-2024a1000epd?src=rss

Comments

Popular posts from this blog

Student Nurses Who Refuse Vaccination Struggle to Complete Degrees

The Clinical Characteristics of Fractures in Pediatric Patients Exposed to Proton Pump Inhibitors